Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Beasley R et al. | Comparative vascular effects of histamine, prostaglandin (PG) D2 and its metabolite 9 alpha,11 beta-PGF2 in human skin. | 1988 | Clin. Allergy | pmid:3242978 |
Thomas RK et al. | Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. | 2005 | Clin. Cancer Res. | pmid:16299251 |
Shin SW et al. | 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. | 2009 | Clin. Cancer Res. | pmid:19690198 |
Koyama M et al. | Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis. | 2010 | Clin. Cancer Res. | pmid:20371690 |
Thévenon C et al. | Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. | 2001 | Clin. Chem. | pmid:11274037 |
Nakagawa T et al. | A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old. | 2013 | Clin. Chim. Acta | pmid:23603101 |
Weiler H et al. | Studies on the effects of aminopterin and methotrexate on the release of prostaglandin PGE2, PGD2, and PGI2 from small intestine in the rat in vivo. | 1991 | Clin. Chim. Acta | pmid:1769112 |
Charlesworth EN et al. | Cutaneous late-phase response in food-allergic children and adolescents with atopic dermatitis. | 1993 | Clin. Exp. Allergy | pmid:7687509 |
Pipkorn U | H1-antagonists as a tool in clarifying the pathophysiology of nasal allergy. | 1990 | Clin. Exp. Allergy | pmid:1699643 |
de Graaf-in t Veld C et al. | Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls. | 1996 | Clin. Exp. Allergy | pmid:8877155 |
Lewis A et al. | Heterogeneity in the responses of human lung mast cells to stem cell factor. | 2013 | Clin. Exp. Allergy | pmid:23278880 |
Genovese A et al. | Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells. | 1997 | Clin. Exp. Allergy | pmid:9179431 |
Wang DY et al. | Prostaglandin D2 measurement in nasal secretions is not a reliable marker for mast cell activation in atopic patients. | 1995 | Clin. Exp. Allergy | pmid:8821304 |
Okayama Y et al. | Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. | 1992 | Clin. Exp. Allergy | pmid:1375128 |
Benyon RC | The human skin mast cell. | 1989 | Clin. Exp. Allergy | pmid:2667702 |
Shin MH et al. | The effect of azelastine on the early allergic response. | 1992 | Clin. Exp. Allergy | pmid:1349259 |
Wagenmann M et al. | Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2. | 1996 | Clin. Exp. Allergy | pmid:8732233 |
Salari H and Chan-Yeung M | Interleukin-1 potentiates antigen-mediated arachidonic acid metabolite formation in mast cells. | 1989 | Clin. Exp. Allergy | pmid:2513105 |
Hewson CA et al. | A differential role for ceramide kinase in antigen/FcɛRI-mediated mast cell activation and function. | 2011 | Clin. Exp. Allergy | pmid:21255156 |
Blom HM et al. | Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. | 1997 | Clin. Exp. Allergy | pmid:9249272 |
Ono E et al. | Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. | 2009 | Clin. Exp. Allergy | pmid:19128354 |
Levy JH | Biomarkers in the diagnosis of anaphylaxis: making nature disclose her mysteries. | 2009 | Clin. Exp. Allergy | pmid:19032357 |
Makker HK et al. | Airway endothelin levels in asthma: influence of endobronchial hypertonic saline challenge. | 1999 | Clin. Exp. Allergy | pmid:10051729 |
Shichijo M et al. | A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep. | 2009 | Clin. Exp. Allergy | pmid:19486034 |
Miadonna A et al. | Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours. | 1999 | Clin. Exp. Allergy | pmid:10383595 |
Yoshimura-Uchiyama C et al. | Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. | 2004 | Clin. Exp. Allergy | pmid:15298571 |
Shichijo M et al. | The effects of anti-asthma drugs on mediator release from cultured human mast cells. | 1998 | Clin. Exp. Allergy | pmid:9824389 |
Obata T et al. | Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. | 1999 | Clin. Exp. Allergy | pmid:10457118 |
Szczeklik A et al. | Safety of a specific COX-2 inhibitor in aspirin-induced asthma. | 2001 | Clin. Exp. Allergy | pmid:11251623 |
Nielsen PN et al. | Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study. | 2001 | Clin. Exp. Allergy | pmid:11591187 |
Higashi N et al. | A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. | 2002 | Clin. Exp. Allergy | pmid:12372129 |
Mutalithas K et al. | CRTH2 expression on T cells in asthma. | 2010 | Clin. Exp. Immunol. | pmid:20491797 |
Vicenzi E et al. | Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid. | 1984 | Clin. Exp. Immunol. | pmid:6432383 |
Eguchi M et al. | Lipopolysaccharide induces proinflammatory cytokines and chemokines in experimental otitis media through the prostaglandin D2 receptor (DP)-dependent pathway. | 2011 | Clin. Exp. Immunol. | pmid:21166666 |
Xue L et al. | Interaction between prostaglandin D and chemoattractant receptor-homologous molecule expressed on Th2 cells mediates cytokine production by Th2 lymphocytes in response to activated mast cells. | 2009 | Clin. Exp. Immunol. | pmid:19220324 |
Kim SH et al. | Toluene diisocyanate (TDI) regulates haem oxygenase-1/ferritin expression: implications for toluene diisocyanate-induced asthma. | 2010 | Clin. Exp. Immunol. | pmid:20345975 |
Nithipatikom K et al. | Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. | 2002 | Clin. Exp. Metastasis | pmid:12498388 |
Wang XS and Lau HY | Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells. | 2006 | Clin. Exp. Pharmacol. Physiol. | pmid:16895550 |
Kanamori S et al. | Effects of dietary fibre on dimethylhydrazine-induced changes in prostanoid concentrations in rat colonic mucosa. | 1995 | Clin. Exp. Pharmacol. Physiol. | pmid:8575110 |
Nolan PN et al. | Participation of prostanoids in chemical activation of the pericardial pressor reflex in dogs. | 1985 Jan-Feb | Clin. Exp. Pharmacol. Physiol. | pmid:3924453 |
Fukui A et al. | Effects of prostaglandin D2 and omeprazole on indomethacin-induced gastric ulcers in rats. | 1988 | Clin. Exp. Pharmacol. Physiol. | pmid:3149561 |
Zhang J et al. | Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts. | 2008 | Clin. Exp. Pharmacol. Physiol. | pmid:18047631 |
Inoue K et al. | Effects of 15-deoxy-Delta12,14-prostaglandin J2 on the expression of Toll-like receptor 4 and 2 in the murine lung in the presence of lipopolysaccharide. | 2005 | Clin. Exp. Pharmacol. Physiol. | pmid:15743408 |
Ray DM et al. | Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands. | 2004 | Clin. Immunol. | pmid:15451478 |
Scher JU and Pillinger MH | 15d-PGJ2: the anti-inflammatory prostaglandin? | 2005 | Clin. Immunol. | pmid:15639643 |
Woolhiser MR et al. | Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. | 2004 | Clin. Immunol. | pmid:15003814 |
Padilla J et al. | Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. | 2002 | Clin. Immunol. | pmid:11987982 |
Reilly CM et al. | Prostaglandin J(2) inhibition of mesangial cell iNOS expression. | 2001 | Clin. Immunol. | pmid:11237557 |
Downard CD et al. | Topical benzoic acid induces the increased biosynthesis of prostaglandin D2 in human skin in vivo. | 1995 | Clin. Pharmacol. Ther. | pmid:7712673 |
Brouwer A et al. | Production of eicosanoids and cytokines by Kupffer cells from young and old rats stimulated by endotoxin. | 1995 | Clin. Sci. | pmid:7720347 |
Robinson C and Holgate ST | Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma. | 1985 | Clin. Sci. | pmid:2981650 |
Horn EH et al. | Longitudinal studies of platelet cyclic AMP during healthy pregnancy and pregnancies at risk of pre-eclampsia. | 1995 | Clin. Sci. | pmid:7545563 |
Oku H and Umino T | Molecular characterization of peroxisome proliferator-activated receptors (PPARs) and their gene expression in the differentiating adipocytes of red sea bream Pagrus major. | 2008 | Comp. Biochem. Physiol. B, Biochem. Mol. Biol. | pmid:18691667 |
He S et al. | Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella). | 2012 | Comp. Biochem. Physiol. C Toxicol. Pharmacol. | pmid:22079418 |
Sawyer MM et al. | Arachidonic acid immunoregulation in lambs persistently infected with border disease virus. | 1993 | Comp. Immunol. Microbiol. Infect. Dis. | pmid:8281741 |
Wallace DI et al. | A Model for Spheroid versus Monolayer Response of SK-N-SH Neuroblastoma Cells to Treatment with 15-Deoxy-PGJ2. | 2016 | Comput Math Methods Med | pmid:28044089 |
Fujishima H et al. | Prostaglandin D2 induces chemotaxis in eosinophils via its receptor CRTH2 and eosinophils may cause severe ocular inflammation in patients with allergic conjunctivitis. | 2005 | Cornea | pmid:16227827 |
Kaye AD et al. | Analysis of thromboxane receptor-mediated responses in the feline pulmonary vascular bed. | 1995 | Crit. Care Med. | pmid:7528116 |
Collin M et al. | Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. | 2004 | Crit. Care Med. | pmid:15090969 |
Trottein F et al. | Role of the D prostanoid receptor 1 in the modulation of immune and inflammatory responses. | 2004 | Crit. Rev. Immunol. | pmid:15663363 |
Frieri M et al. | Mast cell activation syndrome: a review. | 2013 | Curr Allergy Asthma Rep | pmid:23179866 |
Niyonsaba F et al. | Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells. | 2003 | Curr Drug Targets Inflamm Allergy | pmid:14561157 |
Ji Y et al. | Nutrient-induced inflammation in the intestine. | 2011 | Curr Opin Clin Nutr Metab Care | pmid:21587069 |
Huang ZL et al. | Prostaglandins and adenosine in the regulation of sleep and wakefulness. | 2007 | Curr Opin Pharmacol | pmid:17129762 |
Cuzzocrea S | Peroxisome proliferator-activated receptors and acute lung injury. | 2006 | Curr Opin Pharmacol | pmid:16580256 |
Huang ZL et al. | The role of adenosine in the regulation of sleep. | 2011 | Curr Top Med Chem | pmid:21401496 |
Ulven T and Kostenis E | Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation. | 2006 | Curr Top Med Chem | pmid:16918458 |
Sasaguri T and Miwa Y | Prostaglandin J2 family and the cardiovascular system. | 2004 | Curr Vasc Pharmacol | pmid:15320511 |
Arima M and Fukuda T | Prostaglandin D2 receptors DP and CRTH2 in the pathogenesis of asthma. | 2008 | Curr. Mol. Med. | pmid:18691063 |
Stenson WF | The universe of arachidonic acid metabolites in inflammatory bowel disease: can we tell the good from the bad? | 2014 | Curr. Opin. Gastroenterol. | pmid:24837228 |
Mitsumori S | Recent progress in work on PGD2 antagonists for drugs targeting allergic diseases. | 2004 | Curr. Pharm. Des. | pmid:15579050 |
Meier CA et al. | Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma. | 2002 | Cytokine | pmid:12160520 |
Moulin D et al. | Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. | 2007 | Cytokine | pmid:18023358 |
Dubertret L et al. | Biological and cellular responses to grass pollen in sensitive patients. | 1989 | Dermatologica | pmid:2476344 |
Ikai K et al. | Prostaglandin D2, a mediator in both immediate and delayed-type immune reactions in the skin. | 1989 | Dermatologica | pmid:2506083 |
Huddleston KW et al. | Influence of prostaglandin D2 on hemodynamic effects of group B streptococcus in neonatal lambs. | 1986 | Dev Pharmacol Ther | pmid:3530674 |
Wilhelm D et al. | Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. | 2005 | Dev. Biol. | pmid:16185683 |
Moniot B et al. | Hematopoietic prostaglandin D synthase (H-Pgds) is expressed in the early embryonic gonad and participates to the initial nuclear translocation of the SOX9 protein. | 2011 | Dev. Dyn. | pmid:21887724 |
Yasugi E et al. | Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells. | 2006 | Dev. Growth Differ. | pmid:16573735 |
Adams IR and McLaren A | Sexually dimorphic development of mouse primordial germ cells: switching from oogenesis to spermatogenesis. | 2002 | Development | pmid:11874911 |
Moniot B et al. | Prostaglandin D2 acts through the Dp2 receptor to influence male germ cell differentiation in the foetal mouse testis. | 2014 | Development | pmid:25142465 |
Moniot B et al. | The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in Sertoli cells during male sexual differentiation. | 2009 | Development | pmid:19429785 |
Souza SC et al. | BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. | 1998 | Diabetes | pmid:9568706 |
Maggi LB et al. | Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. | 2000 | Diabetes | pmid:10868955 |
Kämpfer H et al. | Wound inflammation in diabetic ob/ob mice: functional coupling of prostaglandin biosynthesis to cyclooxygenase-1 activity in diabetes-impaired wound healing. | 2005 | Diabetes | pmid:15855344 |
Xie Y et al. | Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. | 2006 | Diabetes Obes Metab | pmid:16367886 |
Flachs P et al. | Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. | 2011 | Diabetologia | pmid:21779874 |
Casimir DA et al. | Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. | 1996 | Differentiation | pmid:8765050 |
Fox CC et al. | Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. | 1991 | Dig. Dis. Sci. | pmid:1703070 |
Giardiello FM et al. | Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis. | 1998 | Dig. Dis. Sci. | pmid:9512123 |
Bruck R et al. | Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor. | 2009 | Dig. Dis. Sci. | pmid:18594976 |
Zhang S et al. | Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus. | 2014 | Dis. Esophagus | pmid:24165271 |
Birbian N et al. | No association of PTGDR -441C/T polymorphism with asthma in a North Indian population. | 2011 | Dis. Markers | pmid:22182808 |
PPAR activators and gastroenterology. | 2004 | Drug News Perspect. | pmid:15801147 | |
Pettipher R and Hansel TT | Antagonists of the prostaglandin D2 receptor CRTH2. | 2008 Jul-Aug | Drug News Perspect. | pmid:18836589 |
Campbell A et al. | Overview of allergic mechanisms. Ebastine has more than an antihistamine effect. | 1996 | Drugs | pmid:8983912 |
Woodward DF et al. | Studies on leukotriene D4 as an eosinophil chemoattractant. | 1991 | Drugs Exp Clin Res | pmid:1841046 |
Naclerio R et al. | The role of inflammatory mediators in allergic rhinitis. | 1986 | Ear Nose Throat J | pmid:3459645 |
Fukushima M | Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved. | 1990 | Eicosanoids | pmid:2073399 |
Ney P and Schrör K | PGD2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils. | 1991 | Eicosanoids | pmid:1647806 |